查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451034

2024-2032 年按類型（品牌藥物、學名藥）、產品（定量吸入器、乾粉吸入器）和地區分類的數位劑量吸入器市場報告

Digital Dose Inhaler Market Report by Type (Branded Medication, Generics Medication), Product (Metered Dose Inhaler, Dry Powder Inhaler), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球數位劑量吸入器市場規模達到33億美元。展望未來， IMARC Group預計到2032年市場規模將達到101億美元，2024-2032年複合年成長率（CAGR）為12.7%。對慢性呼吸道疾病管理的日益關注、即時調整的技術進步以及哮喘和慢性阻塞性肺病 (COPD) 等慢性呼吸道疾病 (CRD) 患病率的增加是推動市場的一些主要因素。

數位劑量吸入器 (DDI) 用於向患有氣喘或慢性阻塞性肺病 (COPD) 等呼吸系統疾病的患者輸送藥物。它包括內建感測器和電子功能，可以記錄給藥時間和劑量。它有助於確保遵守規定的治療常規，並更好地了解患者的疾病和藥物的有效性。由於它向用戶提供反饋並幫助他們糾正技術，全球對 DDI 的需求正在不斷成長。

目前，DDI 的採用越來越多，因為它們在藥物傳輸方面提供了更高的便利性和有效性，正在推動市場的成長。除此之外，患者對高效、有效的吸入裝置的需求不斷成長，這提供了積極的市場前景。與此一致的是，由於老年人更容易出現呼吸系統問題，DDI 擴大被老年人採用，這正在推動市場的成長。除此之外，DDI 的使用不斷增加，因為它們使治療更加透明且可能更有效，正在促進市場成長。此外，將人工智慧 (AI) 整合到 DDI 中可以加強對藥物使用情況的監控並向患者提供即時回饋，這正在加強市場的成長。此外，個人對個人化藥物的日益關注正在支持市場的成長。

數位劑量吸入器市場趨勢/促進因素：

慢性呼吸道疾病盛行率不斷上升

氣喘和慢性阻塞性肺病（COPD）等慢性呼吸道疾病（CRD）在全球人群中的盛行率不斷上升，推動了市場的成長。此外，需要管理呼吸系統疾病的個體對增強藥物傳遞系統的需求也在增加。除此之外，DDI 透過確保準確的劑量並向患者和醫療保健提供者提供使用回饋來提供現代解決方案，這提供了積極的市場前景。據此，收集的資料有助於個人化治療計劃、提高藥物治療的依從性，並有可能減少與 CRD 相關的住院治療。

即時調整的技術進步

各家公司不斷改進其 DDI，為患者提供更好的照護和滿意度。它們為醫療保健提供者提供劑量計數、依從性監測和資料傳輸等功能。與此一致的是，這些功能促進了更好的疾病管理，允許即時調整治療計劃，並確保患者有效遵守其用藥時間表，這提供了良好的市場前景。除此之外，DDI 中的技術可以向患者提供有關吸入技術的即時回饋，這對於治療的有效性至關重要。因此，這些進步正在提高患有嚴重呼吸系統疾病的患者的呼吸照護品質。

慢性呼吸道疾病管理日益受到關注

個人和醫療保健提供者對慢性呼吸道疾病（CRD）管理的日益關注正在促進市場的成長。與此相適應，對更有效率、更有效的 CRD 管理的需求不斷增加。除此之外，DDI 可以監測藥物依從性並提供可行的回饋，這在更廣泛的慢性呼吸道疾病管理策略中發揮著至關重要的作用。此外，它們還使醫療保健提供者能夠更好地了解患者的依從性和疾病進展，促進及時干預並為患者帶來更好的結果。此外，DDI 的採用不斷增加，因為它們促進了更好的自我管理，正在推動市場成長。

本報告回答的關鍵問題

  • 2023 年全球數位劑量吸入器市場規模有多大？
  • 2024-2032年全球數位劑量吸入器市場的預期成長率是多少？
  • 推動全球數位劑量吸入器市場的關鍵因素是什麼？
  • COVID-19 對全球數位劑量吸入器市場有何影響？
  • 根據類型，全球數位劑量吸入器市場的細分如何？
  • 基於該產品的全球數位劑量吸入器市場的詳細情形如何？
  • 全球數位劑量吸入器市場的關鍵區域有哪些？
  • 全球數位劑量吸入器市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球數位劑量吸入器市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 品牌藥物
    • 市場走向
    • 市場預測
  • 學名藥
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依產品

  • 定量吸入器
    • 市場走向
    • 市場預測
  • 乾粉吸入器
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 3M Company
    • AstraZeneca plc
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • H&T Presspart Manufacturing Ltd.
    • Koninklijke Philips NV
    • Lupin Limited
    • Novartis AG
    • OPKO Health Inc.
    • Propeller Health (ResMed)
    • Sensirion AG Switzerland
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A3986

The global digital dose inhaler market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.7% during 2024-2032. The growing focus on chronic respiratory disease management, technological advancements for real time adjustments, and increasing prevalence of chronic respiratory diseases (CRDs), such as asthma and chronic obstructive pulmonary disease (COPD, are some of the major factors propelling the market.

A digital dose inhaler (DDI) is used for delivering medication to individuals suffering from respiratory ailments like asthma or chronic obstructive pulmonary disease (COPD). It comprises built-in sensors and electronic features that can record when the medication is administered and the quantity of the dose. It assists in ensuring adherence to prescribed treatment routines and allowing for a better understanding of the disease of the patient and the effectiveness of the medication. As it provides feedback to the users and helps them to correct their technique, the demand for DDI is rising across the globe.

At present, the increasing adoption of DDIs, as they offer enhanced convenience and effectiveness in medication delivery, is bolstering the growth of the market. Besides this, the growing demand for efficient and effective inhalation devices among patients is offering a positive market outlook. In line with this, the rising adoption of DDIs among the geriatric population, as they are more prone to respiratory issues, is propelling the market growth. Apart from this, the increasing utilization of DDIs, as they make treatment more transparent and potentially more effective, is contributing to the market growth. Furthermore, the integration of artificial intelligence (AI) in DDIs to enable enhanced monitoring of medication usage and provide real-time feedback to patients is strengthening the market growth. Moreover, the increasing focus on personalized medicines among individuals is supporting the market growth.

Digital Dose Inhaler Market Trends/Drivers:

Increasing prevalence of chronic respiratory diseases

The rising prevalence of chronic respiratory diseases (CRDs), such as asthma and chronic obstructive pulmonary disease (COPD), among the masses worldwide is contributing to the market growth. In addition, there is an increase in the demand for enhanced drug delivery systems among individuals requiring management of their respiratory conditions. Apart from this, DDIs offer a modern solution by ensuring accurate dosage and providing feedback on usage to both patients and healthcare providers, which is offering a positive market outlook. In line with this, the data collected can be instrumental in personalizing treatment plans, improving adherence to medication regimes, and potentially reducing hospitalizations related to CRDs.

Technological advancements for real time adjustments

Various companies are continuously advancing their DDIs to provide enhanced care and satisfaction to patients. They offer features, such as dose counting, adherence monitoring, and data transmission, to healthcare providers. In line with this, these features promote better disease management, allow for real-time adjustments to treatment plans, and ensure that patients are effectively adhering to their medication schedules, which is offering a favorable market outlook. Apart from this, the technology in DDIs can provide immediate feedback to patients on their inhalation technique, which is crucial for the effectiveness of the treatment. As a result, these advancements are enhancing the quality of respiratory care for patients suffering from severe respiratory disorders.

Growing focus on chronic respiratory disease management

The rising focus on chronic respiratory disease (CRD) management among individuals and healthcare providers is contributing to the growth of the market. In line with this, there is an increase in the demand for more efficient and effective management of CRDs. Apart from this, DDIs can monitor medication adherence and provide actionable feedback, which plays a crucial role in the broader strategy of chronic respiratory disease management. In addition, they enable healthcare providers to have better insights into patient adherence and disease progression, facilitating timely interventions and potentially better outcomes for patients. Furthermore, the rising adoption of DDIs, as they promote better self-management, is propelling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type and product.

Breakup by Type:

Branded Medication

Generics Medication

Branded medication accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes branded medication and generics medication. According to the report, branded medication represented the largest segment. Branded medication refers to drugs that are developed and marketed by pharmaceutical companies under a proprietary name. These medications are often the first of their kind to be introduced to the market and are protected by patents, preventing other companies from selling generic versions for a certain period. The development of branded medications involves thorough research and development (R&D) activities to ensure their efficacy, safety, and quality. Pharmaceutical companies are investing significantly in (R&D) to develop new respiratory medications, which are then sold under a brand name, often at a higher price point due to the innovation and research backing them.

Breakup by Product:

Metered Dose Inhaler

Dry Powder Inhaler

Metered dose inhaler holds the largest share in the industry

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes metered dose inhaler and dry powder inhaler. According to the report, metered dose inhaler accounted for the largest market share. Metered dose inhalers (MDIs) are one of the most common types of inhalers used in respiratory therapy. They are designed to deliver a specific amount of medication to the lungs, with each actuation or press of the inhaler. MDIs consist of a pressurized canister that contains medication in a liquid or aerosol form, housed within a plastic case with a mouthpiece. When the inhaler is actuated, it releases a measured dose of medication in aerosol form for inhalation. MDIs are popular due to their portability, ease of use, and the ability to provide quick relief in acute respiratory situations. They are highly effective for delivering bronchodilators and steroids which are commonly used in the management of conditions like asthma and Chronic Obstructive Pulmonary Disease (COPD).

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest digital dose inhaler market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increasing adoption of advanced respiratory devices. Additionally, the presence of well-established pharmaceutical and medical device companies is offering a positive market outlook. Apart from this, the rising focus on improving respiratory care solutions is contributing to the growth of the market. In addition, increasing incidences of respiratory disorders among individuals are propelling the growth of the market.

Competitive Landscape:

Various companies are investing in research and development (R&D) activities to create DDIs with enhanced features, such as improved dose counting, adherence monitoring, and real-time feedback mechanisms, to cater to the needs of patients and healthcare providers. Apart from this, companies are engaging in collaborations and partnerships to expand their technological capabilities and market reach. In line with this, they are providing more user-friendly and effective solutions for managing respiratory diseases. Besides this, major manufacturers are working on specialized inhaler solutions that are tailored to deliver complex biologics. Furthermore, companies are engaging in marketing and awareness campaigns to educate healthcare providers and patients about the advantages of digital dose inhalers over traditional ones.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

3M Company

AstraZeneca plc

GlaxoSmithKline plc

Glenmark Pharmaceuticals Limited

H&T Presspart Manufacturing Ltd.

Koninklijke Philips N.V.

Lupin Limited

Novartis AG

OPKO Health Inc.

Propeller Health (ResMed)

Sensirion AG Switzerland

Teva Pharmaceutical Industries Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In September 2020, Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd launched two digital maintenance inhalers, such as AirDuo(R) Digihaler(R) (fluticasone propionate and salmeterol) inhalation powder and ArmonAir(R) Digihaler(R) (fluticasone propionate) inhalation powder, for patients with asthma.

In February 2022, AstraZeneca and Honeywell partnered to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has less Global Warming Potential (GWP) than propellants currently used in respiratory medicines.

In July 2023, Lupin launched a pressurized metered dose inhaler for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in Germany.

Key Questions Answered in This Report

  • 1. What was the size of the global digital dose inhaler market in 2023?
  • 2. What is the expected growth rate of the global digital dose inhaler market during 2024-2032?
  • 3. What are the key factors driving the global digital dose inhaler market?
  • 4. What has been the impact of COVID-19 on the global digital dose inhaler market?
  • 5. What is the breakup of the global digital dose inhaler market based on the type?
  • 6. What is the breakup of the global digital dose inhaler market based on the product?
  • 7. What are the key regions in the global digital dose inhaler market?
  • 8. Who are the key players/companies in the global digital dose inhaler market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Dose Inhaler Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Branded Medication
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Generics Medication
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Metered Dose Inhaler
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Dry Powder Inhaler
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 GlaxoSmithKline plc
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
    • 13.3.4 Glenmark Pharmaceuticals Limited
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 H&T Presspart Manufacturing Ltd.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Koninklijke Philips N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Lupin Limited
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 OPKO Health Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Propeller Health (ResMed)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Sensirion AG Switzerland
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
    • 13.3.12 Teva Pharmaceutical Industries Ltd.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials

List of Figures

  • Figure 1: Global: Digital Dose Inhaler Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Dose Inhaler Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Digital Dose Inhaler Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Digital Dose Inhaler Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Digital Dose Inhaler Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Digital Dose Inhaler Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Digital Dose Inhaler (Branded Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Digital Dose Inhaler (Branded Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Digital Dose Inhaler (Generics Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Digital Dose Inhaler (Generics Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Digital Dose Inhaler (Metered Dose Inhaler) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Digital Dose Inhaler (Dry Powder Inhaler) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: North America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: North America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: United States: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: United States: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Canada: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Canada: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Asia-Pacific: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Asia-Pacific: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: China: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: China: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Japan: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Japan: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: India: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: India: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: South Korea: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: South Korea: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Australia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Australia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Indonesia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Indonesia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Europe: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Europe: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Germany: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Germany: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: France: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: France: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United Kingdom: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United Kingdom: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Italy: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Italy: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Spain: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Spain: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Russia: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Russia: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Latin America: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Latin America: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Brazil: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Brazil: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Mexico: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Mexico: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Middle East and Africa: Digital Dose Inhaler Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Middle East and Africa: Digital Dose Inhaler Market: Breakup by Country (in %), 2023
  • Figure 63: Middle East and Africa: Digital Dose Inhaler Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Global: Digital Dose Inhaler Industry: SWOT Analysis
  • Figure 65: Global: Digital Dose Inhaler Industry: Value Chain Analysis
  • Figure 66: Global: Digital Dose Inhaler Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Dose Inhaler Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Digital Dose Inhaler Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Digital Dose Inhaler Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Digital Dose Inhaler Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Digital Dose Inhaler Market: Competitive Structure
  • Table 6: Global: Digital Dose Inhaler Market: Key Players